CANC ETF largest holding is RVMD at 6.54% as of Aug 18, 2026
Tema Oncology ETF
RVMD is CANC's largest holding at 6.54% of the fund as of Aug 18, 2026. CANC is Tema Oncology ETF.
| # | Ticker | Name | Weight | Cumulative | Shares | Mkt value | Sector | Industry |
|---|---|---|---|---|---|---|---|---|
| 1 | R | Revolution Medicines IncHealth Care · Biotechnology | 6.54% | 6.5% | 63,643 | $13.75M | Health Care | Biotechnology |
| 2 | L | Eli Lilly & Co.Health Care · Pharmaceuticals | 5.39% | 11.9% | 9,252 | $11.34M | Health Care | Pharmaceuticals |
| Sector and industry · Pro | ||||||||
| 3 | C | Cogent Biosciences Inc | 4.96% | 16.9% | 278,800 | $10.43M | ||
| 4 | R | Roche Holding Ag Dividend Right Cert | 4.26% | 21.1% | 161,380 | $8.96M | ||
| 5 | N | Novartis Ag - | 3.79% | 24.9% | 51,609 | $7.97M | ||
| 6 | B | Bristol-Myers Squibb Co. | 3.49% | 28.4% | 111,076 | $7.34M | ||
| 7 | A | AbbVie Inc. | 3.31% | 31.7% | 26,890 | $6.96M | ||
| 8 | O | Beigene, Ltd. Adr | 3.22% | 35.0% | 18,365 | $6.78M | ||
| 9 | M | Merck & Company Inc | 3.22% | 38.2% | 50,046 | $6.76M | ||
| 10 | J | Johnson & Johnson - | 3.11% | 41.3% | 24,155 | $6.55M | ||
| 11 | H | Halozyme Therapeutics Inc | 3.10% | 44.4% | 62,133 | $6.52M | ||
| 12 | I | Immunome Inc | 2.98% | 47.4% | 227,174 | $6.26M | ||
| 13 | — | Genmab A/s ADR | 2.83% | 50.2% | 180,357 | $5.94M | ||
| 14 | C | Cg Oncology Inc | 2.77% | 53.0% | 76,283 | $5.82M | ||
| 15 | E | Exelixis Inc | 2.52% | 55.5% | 99,805 | $5.30M | ||
| 16 | I | Ideaya Biosciences Inc | 2.52% | 58.0% | 139,943 | $5.31M | ||
| 17 | B | Bridgebio Pharma Inc_None_0 | 2.10% | 60.1% | 53,099 | $4.41M | ||
| 18 | E | Enliven Therapeutics Inc | 2.09% | 62.2% | 73,262 | $4.40M | ||
| 19 | L | Legend Biotech, Adr | 2.03% | 64.2% | 194,694 | $4.27M | ||
| 20 | A | Amgen Inc. | 2.01% | 66.2% | 9,937 | $4.23M | ||
| 21 | — | AstraZeneca PLC | 1.94% | 68.2% | 25,559 | $4.08M | ||
| 22 | Z | Zai Lab Ltd | 1.93% | 70.1% | 158,638 | $4.06M | ||
| 23 | C | Celcuity Inc | 1.87% | 72.0% | 42,141 | $3.93M | ||
| 24 | R | Relay Therapeutics Inc | 1.79% | 73.8% | 182,110 | $3.75M | ||
| 25 | E | Erasca Inc. | 1.76% | 75.5% | 204,789 | $3.71M | ||
| 26 | U | Urogen Pharma Ltd Com Ils0.01 | 1.40% | 76.9% | 60,279 | $2.95M | ||
| 27 | N | Nuvation Bio Inc | 1.36% | 78.3% | 409,814 | $2.85M | ||
| 28 | — | Zymeworks Inc. | 1.35% | 79.6% | 108,801 | $2.84M | ||
| 29 | R | Arcus Biosciences Inc | 1.20% | 80.8% | 85,643 | $2.53M | ||
| 30 | I | Iovance Biotherapeutics Inc | 1.13% | 82.0% | 337,740 | $2.37M | ||
| 31 | T | Tyra Biosciences Inc | 1.04% | 83.0% | 83,931 | $2.19M | ||
| 32 | C | Corvus Pharmaceuticals Inc | 0.99% | 84.0% | 140,386 | $2.08M | ||
| 33 | K | Kura Oncology Inc | 0.99% | 85.0% | 168,577 | $2.08M | ||
| 34 | G | Gilead Sciences | 0.98% | 86.0% | 14,406 | $2.07M | ||
| 35 | T | Tango Therapeutics Inc. | 0.98% | 87.0% | 80,616 | $2.05M | ||
| 36 | A | Anaptysbio Inc | 0.90% | 87.9% | 32,208 | $1.90M | ||
| 37 | S | Summit Therapeutics Inccommon Stock | 0.90% | 88.8% | 147,579 | $1.89M | ||
| 38 | N | Natera Inc | 0.89% | 89.6% | 5,988 | $1.87M | ||
| 39 | R | Replimune Group Inc | 0.79% | 90.4% | 106,637 | $1.66M | ||
| 40 | — | Cash & Cash Equivalents | 0.78% | 91.2% | - | $1.64M | ||
| 41 | — | Immunocore Holdings Ltd Adr | 0.76% | 92.0% | 44,164 | $1.59M | ||
| 42 | I | Immatics Nv | 0.76% | 92.7% | 176,673 | $1.61M | ||
| 43 | G | Guardant Health, Inc | 0.66% | 93.4% | 8,637 | $1.38M | ||
| 44 | O | ORIC Pharmaceuticals, Inc. | 0.65% | 94.0% | 97,427 | $1.36M | ||
| 45 | C | Cullinan Therapeutics Inc | 0.64% | 94.7% | 64,713 | $1.35M | ||
| 46 | S | Syndax Pharmaceuticals Inc | 0.51% | 95.2% | 54,066 | $1.08M | ||
| 47 | C | Candel Therapeutics Inc. | 0.49% | 95.7% | 84,929 | $1.02M | ||
| 48 | B | Bicara Therapeutics, Inc. | 0.44% | 96.1% | 36,891 | $919.3K | ||
| 49 | J | Janux Therapeutics Inc | 0.43% | 96.6% | 53,073 | $900.1K | ||
| 50 | O | Olema Pharmaceuticals Inc | 0.42% | 97.0% | 82,164 | $875.0K | ||
| More holdings · Pro | ||||||||
CANC ETF All Holdings
CANC holdings total 58 positions. The top 10 holdings account for 41.3% of the fund, led by Revolution Medicines Inc at 6.5%, Eli Lilly & Co. at 5.4%, Cogent Biosciences Inc at 5.0%.
CANC portfolio concentration is moderate, with the top 10 representing 41.3% of total assets. The largest sector exposure is Health Care at 88.1%.
CANC sectors provide a detailed breakdown. CANC overlap shows how holdings compare to other funds in your portfolio.
CANC ETF Holdings
59 of 58 holdings
- 1
Revolution Medicines Inc
RVMDHealth Care6.54% - 2
Eli Lilly & Co.
LLYHealth Care5.39% - 3
Cogent Biosciences Inc
COGTHealth Care4.96% - 4
Roche Holding Ag Dividend Right Cert
RHHBYUnknown4.26% - 5
Novartis Ag - Common
NOVN:SMUnknown3.79% - 6
Bristol-Myers Squibb Co.
BMYHealth Care3.49% - 7
Abbvie Inc.
ABBVHealth Care3.31% - 8
Beigene, Ltd. Adr
BGNEHealth Care3.22% - 9
Merck & Company Inc
MRKHealth Care3.22% - 10
Johnson & Johnson - Common
JNJHealth Care3.11% - 11
Halozyme Therapeutics Inc
HALOHealth Care3.10% - 12
Immunome Inc
IMNMHealth Care2.98% - 13
Genmab A/s ADR
GMAB:COHealth Care2.83% - 14
Cg Oncology Inc
CGONHealth Care2.77% - 15
Exelixis Inc
EXELHealth Care2.52% - 16
Ideaya Biosciences Inc
IDYAHealth Care2.52% - 17
Bridgebio Pharma Inc_None_0
BBIOHealth Care2.10% - 18
Enliven Therapeutics Inc
ELVNHealth Care2.09% - 19
Legend Biotech, Adr
LEGNHealth Care2.03% - 20
Amgen Inc.
AMGNHealth Care2.01% - 21
AstraZeneca PLC
AZN:LNUnknown1.94% - 22
Zai Lab Ltd
ZLABHealth Care1.93% - 23
Celcuity Inc Com
CELCHealth Care1.87% - 24
Relay Therapeutics Inc
RLAYHealth Care1.79% - 25
Erasca Inc.
ERASHealth Care1.76% - 26
Urogen Pharma Ltd Com Ils0.01
URGNHealth Care1.40% - 27
Nuvation Bio Inc
NUVBHealth Care1.36% - 28
Zymeworks Inc. Common Stock
ZYME:CAHealth Care1.35% - 29
Arcus Biosciences Inc
RCUSHealth Care1.20% - 30
Iovance Biotherapeutics Inc
IOVAHealth Care1.13% - 31
Tyra Biosciences Inc
TYRAHealth Care1.04% - 32
Corvus Pharmaceuticals Inc
CRVSHealth Care0.99% - 33
Kura Oncology Inc
KURAHealth Care0.99% - 34
Gilead Sciences
GILDHealth Care0.98% - 35
Tango Therapeutics Inc.
TNGXHealth Care0.98% - 36
Anaptysbio Inc
ANABHealth Care0.90% - 37
Summit Therapeutics Inccommon Stock
SMMTHealth Care0.90% - 38
Natera Inc
NTRAHealth Care0.89% - 39
Replimune Group Inc Com
REPLHealth Care0.79% - 40
Cash & Cash Equivalents
Other0.78% - 41
Immunocore Holdings Ltd Adr
IMCR:LNHealth Care0.76% - 42
Immatics Nv
4A3:BEHealth Care0.76% - 43
Guardant Health, Inc
GHHealth Care0.66% - 44
ORIC Pharmaceuticals, Inc.
ORICHealth Care0.65% - 45
Cullinan Therapeutics Inc
CGEMHealth Care0.64% - 46
Syndax Pharmaceuticals Inc
SNDXHealth Care0.51% - 47
Candel Therapeutics Inc.
CADLHealth Care0.49% - 48
Bicara Therapeutics, Inc.
BCAXHealth Care0.44% - 49
Janux Therapeutics Inc
JANXHealth Care0.43% - 50
Olema Pharmaceuticals Inc
OLMAHealth Care0.42% - 51
BRIDGEBIO ONCOLOGY THERAPEUTICS IN
BBOTUnknown0.41% - 52
First Tracks Biotherapeutics, Inc.
TRAXUnknown0.39% - 53
Arvinas Inc
ARVNHealth Care0.38% - 54
Cytomx Therapeutics Inc
CTMXHealth Care0.38% - 55
ARRIVENT BIOPHARMA INC
AVBPHealth Care0.31% - 56
Inhibrx Biosciences Inc
INBXHealth Care0.31% - 57
Amani Gold Ltd
ANL:AUUnknown0.31% - 58
Autolus Therapeutics Ltd. Adr
AUTL:LNHealth Care0.29% - 59
Regeneron Pharmaceuticals, Inc.
REGNHealth Care0.25%
| # | Company | Ticker | Sector | Industry | Weight |
|---|---|---|---|---|---|
| 1 | Revolution Medicines Inc | RVMD | 6.540% | ||
| 2 | Eli Lilly & Co. | LLY | 5.390% | ||
| 3 | Cogent Biosciences Inc | COGT | 4.960% | ||
| 4 | Roche Holding Ag Dividend Right Cert | RHHBY | 4.260% | ||
| 5 | Novartis Ag - Common | NOVN:SM | 3.790% | ||
| 6 | Bristol-Myers Squibb Co. | BMY | 3.490% | ||
| 7 | Abbvie Inc. | ABBV | 3.310% | ||
| 8 | Beigene, Ltd. Adr | BGNE | 3.220% | ||
| 9 | Merck & Company Inc | MRK | 3.220% | ||
| 10 | Johnson & Johnson - Common | JNJ | 3.110% | ||
| 11 | Halozyme Therapeutics Inc | HALO | 3.100% | ||
| 12 | Immunome Inc | IMNM | 2.980% | ||
| 13 | Genmab A/s ADR | GMAB:CO | 2.830% | ||
| 14 | Cg Oncology Inc | CGON | 2.770% | ||
| 15 | Exelixis Inc | EXEL | 2.520% | ||
| 16 | Ideaya Biosciences Inc | IDYA | 2.520% | ||
| 17 | Bridgebio Pharma Inc_None_0 | BBIO | 2.100% | ||
| 18 | Enliven Therapeutics Inc | ELVN | 2.090% | ||
| 19 | Legend Biotech, Adr | LEGN | 2.030% | ||
| 20 | Amgen Inc. | AMGN | 2.010% | ||
| 21 | AstraZeneca PLC | AZN:LN | 1.940% | ||
| 22 | Zai Lab Ltd | ZLAB | 1.930% | ||
| 23 | Celcuity Inc Com | CELC | 1.870% | ||
| 24 | Relay Therapeutics Inc | RLAY | 1.790% | ||
| 25 | Erasca Inc. | ERAS | 1.760% | ||
| 26 | Urogen Pharma Ltd Com Ils0.01 | URGN | 1.400% | ||
| 27 | Nuvation Bio Inc | NUVB | 1.360% | ||
| 28 | Zymeworks Inc. Common Stock | ZYME:CA | 1.350% | ||
| 29 | Arcus Biosciences Inc | RCUS | 1.200% | ||
| 30 | Iovance Biotherapeutics Inc | IOVA | 1.130% | ||
| 31 | Tyra Biosciences Inc | TYRA | 1.040% | ||
| 32 | Corvus Pharmaceuticals Inc | CRVS | 0.990% | ||
| 33 | Kura Oncology Inc | KURA | 0.990% | ||
| 34 | Gilead Sciences | GILD | 0.980% | ||
| 35 | Tango Therapeutics Inc. | TNGX | 0.980% | ||
| 36 | Anaptysbio Inc | ANAB | 0.900% | ||
| 37 | Summit Therapeutics Inccommon Stock | SMMT | 0.900% | ||
| 38 | Natera Inc | NTRA | 0.890% | ||
| 39 | Replimune Group Inc Com | REPL | 0.790% | ||
| 40 | Cash & Cash Equivalents | - | 0.780% | ||
| 41 | Immunocore Holdings Ltd Adr | IMCR:LN | 0.760% | ||
| 42 | Immatics Nv | 4A3:BE | 0.760% | ||
| 43 | Guardant Health, Inc | GH | 0.660% | ||
| 44 | ORIC Pharmaceuticals, Inc. | ORIC | 0.650% | ||
| 45 | Cullinan Therapeutics Inc | CGEM | 0.640% | ||
| 46 | Syndax Pharmaceuticals Inc | SNDX | 0.510% | ||
| 47 | Candel Therapeutics Inc. | CADL | 0.490% | ||
| 48 | Bicara Therapeutics, Inc. | BCAX | 0.440% | ||
| 49 | Janux Therapeutics Inc | JANX | 0.430% | ||
| 50 | Olema Pharmaceuticals Inc | OLMA | 0.420% | ||
| 51 | BRIDGEBIO ONCOLOGY THERAPEUTICS IN | BBOT | 0.410% | ||
| 52 | First Tracks Biotherapeutics, Inc. | TRAX | 0.390% | ||
| 53 | Arvinas Inc | ARVN | 0.380% | ||
| 54 | Cytomx Therapeutics Inc | CTMX | 0.380% | ||
| 55 | ARRIVENT BIOPHARMA INC | AVBP | 0.310% | ||
| 56 | Inhibrx Biosciences Inc | INBX | 0.310% | ||
| 57 | Amani Gold Ltd | ANL:AU | 0.310% | ||
| 58 | Autolus Therapeutics Ltd. Adr | AUTL:LN | 0.290% | ||
| 59 | Regeneron Pharmaceuticals, Inc. | REGN | 0.250% |












































